• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday

    6/27/22 4:26:40 AM ET
    $AGTC
    $ANEB
    $ARL
    $AVTE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGTC alert in real time by email

    Gainers

    • USA Truck, Inc. (NASDAQ:USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
    • Benitec Biopharma Inc. (NASDAQ:BNTC) jumped 64.9% to close at $1.22. Benitec Biopharma, last month, posted a Q3 loss of $0.40 per share.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) climbed 55.2% to close at $2.70 after jumping 26% on Thursday. ToughBuilt Industries reported closing of $6 million public offering.
    • T Stamp Inc. (NASDAQ:IDAI) gained 36% to close at $1.85.
    • Sera Prognostics, Inc. (NASDAQ:SERA) jumped 34.6% to close at $1.75.
    • WiSA Technologies, Inc. (NASDAQ:WISA) surged 32.9% to close at $0.80.
    • FingerMotion, Inc. (NASDAQ:FNGR) rose 30.4% to settle at $1.80.
    • Boxed, Inc. (NYSE:BOXD) gained 29.6% to close at $2.32.
    • Ikena Oncology, Inc. (NASDAQ:IKNA) surged 29.4% to close at $5.37. Ikena Oncology recently received Fast Track designation from the U.S. Food and Drug Administration (FDA) for IK-930, in patients with unresectable NF2-deficient malignant pleural mesothelioma (MPM).
    • Surrozen, Inc. (NASDAQ:SRZN) surged 28.5% to settle at $3.43. Surrozen recently initiated dosing in Phase 1 clinical trial of SZN-043 for severe alcoholic hepatitis.
    • Zendesk, Inc. (NYSE:ZEN) gained 28% to close at $74.17. Global investment firms Permira and Hellman & Friedman LLC agreed to takeover Zendesk in an all-cash transaction that values Zendesk at $10.2 billion.
    • Wrap Technologies, Inc. (NASDAQ:WRAP) rose 25.7% to close at $2.35 in possible anticipation of protests after the US Supreme Court overturned Roe vs Wade. The company develops policing solutions to law enforcement and security personnel.
    • Blue Star Foods Corp. (NASDAQ:BSFC) gained 24.4% to settle at $1.48. Blue Star Foods recently announced inclusion in Russell Microcap Index.
    • Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) climbed 23.8% to close at $4.99. Anebulo Pharmaceuticals will announce topline data for ANEB-001 from an ongoing Phase 2 clinical trial for acute cannabinoid intoxication on Tuesday July 5, 2022.
    • Mega Matrix Corp. (NASDAQ:MTMT) gained 23.6% to close at $1.31.
    • U.S. Xpress Enterprises, Inc. (NYSE:USX) rose 22.6% to settle at $2.98.
    • Femasys Inc. (NASDAQ:FEMY) gained 22.1% to close at $1.88.
    • SAB Biotherapeutics, Inc. (NASDAQ:SABS) jumped 22% to settle at $1.50.
    • Aerovate Therapeutics, Inc. (NASDAQ:AVTE) gained 21.8% to close at $16.55.
    • Lottery.com Inc. (NASDAQ:LTRY) jumped 20.7% to close at $1.34.
    • Moving iMage Technologies, Inc. (NYSE:MITQ) surged 20.4% to close at $1.30 after the company announced a $1 million buyback.
    • Bausch Health Companies Inc. (NYSE:BHC) surged 20.4% to close at $8.75.
    • Novonix Limited (NASDAQ:NVX) jumped 20.3% to close at $7.28.
    • TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) surged 20.1% to settle at $1.67. TRACON Pharmaceuticals 10% owner Opaleye Management Inc acquired a total of 841,989 shares at an average price of $1.31.
    • Eqonex Limited (NASDAQ:EQOS) rose 19% to close at $0.9150.
    • Viveve Medical, Inc. (NASDAQ:VIVE) jumped 18.7% to settle at $0.8550.
    • Silver Spike Investment Corp. (NASDAQ:SSIC) surged 18.7% to close at $9.25.
    • HilleVax, Inc. (NASDAQ:HLVX) gained 18% to settle at $14.04.
    • CPI Card Group Inc. (NASDAQ:PMTS) surged 18% to close at $16.89.
    • Wave Life Sciences Ltd. (NASDAQ:WVE) rose 17.5% to close at $2.82.
    • Vigil Neuroscience, Inc. (NASDAQ:VIGL) gained 17.3% to settle at $2.91. Vigil Neuroscience recently expanded VGL101 Phase 1 trial to Australia.
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) jumped 17.2% to close at $1.36.
    • Evofem Biosciences, Inc. (NASDAQ:EVFM) gained 17% to close at $0.3719. Evofem Biosciences recently announced results of post hoc analysis of registrational Phase 3 AMPOWER trial.
    • Dragon Victory International Limited (NASDAQ:LYL) climbed 16.6% to close at $0.8501.
    • Royal Caribbean Cruises Ltd. (NYSE:RCL) climbed 15.8% to close at $41.76 in sympathy with Carnival, which reported a 50% increase revenue from Q1 to Q2.
    • Maris-Tech Ltd. (NASDAQ:MTEK) gained 15.1% to close at $1.37. Maris-Tech recently received a $300,000 purchase order from a leading Israeli defense company for its Opal platform.
    • Centogene N.V. (NASDAQ:CNTG) surged 15.1% to settle at $2.43. CENTOGENE and Agios recently expanded partnership for clinical development of PYRUKYND to treat children with rare blood disease.
    • LogicMark, Inc. (NASDAQ:LGMK) climbed 15% to close at $1.30.
    • U.S. Gold Corp. (NYSE:USAU) rose 14.7% to settle at $4.36.
    • Forafric Global PLC (NASDAQ:AFRI) gained 13.8% to settle at $6.81.
    • Carnival Corporation (NYSE:CCL) climbed 12.4% to close at $10.85 after the company provided a Q2 business update. Revenue increased by nearly 50% in Q2 of 2022 compared to Q1 2022.
    • Oceaneering International, Inc. (NYSE:OII) climbed 12.1% to close at $9.90.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) rose 12% to close at $0.3644.
    • Molecular Templates, Inc. (NASDAQ:MTEM) gained 11.6% to close at $1.06.
    • Palatin Technologies, Inc. (NYSE:PTN) jumped 10% to close at $0.3070. Palatin Technologies, last month, posted a Q3 loss of $0.03 per share.
    • WISeKey International Holding AG (NASDAQ:WKEY) climbed 8% to close at $2.71.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) gained 6.8% to close at $0.9380.
    • Evoke Pharma, Inc. (NASDAQ:EVOK) rose 5.2% to close at $3.04. The Florida Medicaid Pharmaceutical & Therapeutics Committee recently approved adding GIMOTI to its preferred drug list immediately.

     

     


    Losers

    • Tenax Therapeutics, Inc. (NASDAQ:TENX) shares tumbled 46.9% to close at $0.3104.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) fell 42.8% to settle at $0.6120 on Friday.
    • Meta Materials Inc. (NASDAQ:MMAT) dropped 38.7% to close at $1.17.
    • Quotient Limited (NASDAQ:QTNT) dipped 35% to close at $0.26 on Friday after the company priced an offering of 66,666,667 shares for aggregate gross proceeds of $20 million.
    • InflaRx N.V. (NASDAQ:IFRX) fell 33.8% to close at $0.7810.
    • Universe Pharmaceuticals INC (NASDAQ:UPC) shares dipped 32.8% to close at $0.6590.
    • Genius Group Limited (NYSE:GNS) fell 31.5% to close at $6.55.
    • CalAmp Corp. (NASDAQ:CAMP) fell 30.5% to settle at $4.99 after the company reported worse-than-expected Q1 adjusted EPS and sales results.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) fell 28.7% to close at $12.62 on Friday.
    • BioSig Technologies, Inc. (NASDAQ:BSGM) fell 26.3% to close at $0.7371 after the company reported pricing of public offering of common stock.
    • Applied Genetic Technologies Corporation (NASDAQ:AGTC) dropped 25.1% to settle at $0.6170.
    • Avaya Holdings Corp. (NYSE:AVYA) shares fell 23.7% to settle at $2.87.
    • Terran Orbital Corporation (NYSE:LLAP) fell 22.1% to close at $5.05.
    • Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) declined 20.9% to close at $0.87.
    • Pardes Biosciences, Inc. (NASDAQ:PRDS) dipped 19.9% to close at $3.46.
    • Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) dropped 19.6% to settle at $2.96.
    • FlexShopper, Inc. (NASDAQ:FPAY) fell 18.5% to close at $0.8555. FlexShopper, last month, posted a Q1 loss of $0.14 per share.
    • DiaMedica Therapeutics Inc. (NASDAQ:DMAC) dropped 18.1% to settle at $1.86. DiaMedica Therapeutics, last month, posted a Q1 loss of $0.13 per share.
    • Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 16.3% to close at $1.03.
    • MiNK Therapeutics, Inc. (NASDAQ:INKT) dropped 15.2% to settle at $1.51. MiNK Therapeutics, last month, posted a Q1 loss of $0.23 per share.
    • American Realty Investors, Inc. (NYSE:ARL) fell 14.1% to close at $13.87.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) fell 13.6% to close at $2.36 after jumping 263% on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown offering.
    • Valneva SE (NASDAQ:VALN) fell 13.3% to close at $27.27. The Committee for Medicinal Products for Human Use of the European Medicines Agency recommended marketing authorization in Europe for the company's COVID-19 vaccine candidate for use as primary vaccination in people from 18 to 50 years of age.
    • TDH Holdings, Inc. (NASDAQ:PETZ) declined 8.2% to close at $2.70.
    • LendingTree, Inc. (NASDAQ:TREE) fell 7.9% to close at $50.55 after the company cut its Q2 revenue guidance.
    • Phoenix Motor Inc. (NASDAQ:PEV) shares fell 7.5% to close at $6.14 after jumping around 14% on Thursday.
    • 22nd Century Group, Inc. (NASDAQ:XXII) fell 5.8% to close at $2.42.
    Get the next $AGTC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGTC
    $ANEB
    $ARL
    $AVTE

    CompanyDatePrice TargetRatingAnalyst
    Surrozen Inc.
    $SRZN
    2/19/2026$40.00Overweight
    Cantor Fitzgerald
    Wave Life Sciences Ltd.
    $WVE
    2/5/2026$38.00Buy
    BofA Securities
    SAB Biotherapeutics Inc.
    $SABS
    12/19/2025$15.00Buy
    Guggenheim
    Sera Prognostics Inc.
    $SERA
    12/15/2025$5.00Buy
    Jefferies
    Palatin Technologies Inc.
    $PTN
    12/12/2025$60.00Buy
    Laidlaw
    Wave Life Sciences Ltd.
    $WVE
    12/12/2025$20.00 → $33.00Outperform
    Wedbush
    Bausch Health Companies Inc.
    $BHC
    12/9/2025$8.00Equal Weight
    Barclays
    Wave Life Sciences Ltd.
    $WVE
    12/9/2025$27.00Sector Perform → Outperform
    RBC Capital Mkts
    More analyst ratings

    $AGTC
    $ANEB
    $ARL
    $AVTE
    SEC Filings

    View All

    Royal Caribbean Cruises Ltd. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - ROYAL CARIBBEAN CRUISES LTD (0000884887) (Filer)

    2/27/26 4:30:45 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    SEC Form DEFM14A filed by Carnival Corporation

    DEFM14A - CARNIVAL CORP (0000815097) (Filer)

    2/27/26 4:16:55 PM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    SEC Form 424B3 filed by Carnival Corporation

    424B3 - CARNIVAL CORP (0000815097) (Filer)

    2/27/26 4:14:34 PM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    $AGTC
    $ANEB
    $ARL
    $AVTE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Francis Chris exercised 33,194 units of Ordinary Shares at a strike of $4.28 and sold $499,593 worth of Ordinary Shares (33,194 units at $15.05) (SEC Form 4)

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    2/27/26 9:00:03 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP, Controller & CAO Lee Steven Hyosig was granted 45,868 shares, increasing direct ownership by 168% to 73,239 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    2/27/26 5:23:05 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, US Pharma Lenar Aimee J. was granted 157,139 shares and covered exercise/tax liability with 17,578 shares, increasing direct ownership by 54% to 400,335 units (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    2/27/26 5:21:50 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    ATLANTA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today it has granted to two new non-executive employees who began their employment with Femasys in February 2026 options to purchase 185,000 shares of Femasys common stock. These inducement grants were granted at an exercise price per share of $0.50 and $0.57, equal to the closing price of Femasys common stock on the date of employment as reported by Nasdaq. This grant was approved by the Compensation Committee of Femasys' Board of Directors and made as an inducement

    2/27/26 5:26:33 PM ET
    $FEMY
    Medical/Dental Instruments
    Health Care

    Royal Caribbean Group announces completion of offering of $1.25 billion senior unsecured notes due 2033 and $1.25 billion senior unsecured notes due 2038

    MIAMI, Feb. 27, 2026 /PRNewswire/ -- Royal Caribbean Cruises Ltd. (NYSE:RCL) (the "Company") today announced that it has completed its registered public offering of $1.25 billion aggregate principal amount of 4.750% senior unsecured notes due 2033 (the "2033 Notes") and $1.25 billion aggregate principal amount of 5.250% senior unsecured notes due 2038 (the "2038 Notes" and, together with the 2033 Notes, the "Notes"). The 2033 Notes will mature on May 15, 2033 and the 2038 Notes will mature on February 27, 2038, unless earlier redeemed or repurchased. The Company intends to use t

    2/27/26 4:15:00 PM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    THE CORMORANT AT 55 SOUTH: SILVERSEA UNVEILS ALL PUBLIC SPACES OF HIGHLY ANTICIPATED SOUTHERNMOST HOTEL

    The Cormorant will create the most convenient, comfortable, and seamless way to explore AntarcticaMIAMI, Feb. 26, 2026 /PRNewswire/ -- Silversea, the leading experiential luxury and expedition travel brand, has unveiled the interior spaces of its new 150-room hotel, The Cormorant at 55 South, in Puerto Williams, Chile, designed to streamline travel to one of the world's most remote destinations, while enhancing the overall guest experience. Set to welcome guests in October 2026, The Cormorant at 55 South, named for its unique location and the resilient seabird, will serve as a cornerstone of Silversea's innovative Antarctica Fly Cruise program, offering some of the most diverse polar experie

    2/26/26 10:49:00 AM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Surrozen with a new price target

    Cantor Fitzgerald initiated coverage of Surrozen with a rating of Overweight and set a new price target of $40.00

    2/19/26 7:52:22 AM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BofA Securities initiated coverage on Wave Life Sciences with a new price target

    BofA Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $38.00

    2/5/26 9:31:24 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on SAB BIO with a new price target

    Guggenheim initiated coverage of SAB BIO with a rating of Buy and set a new price target of $15.00

    12/19/25 8:51:08 AM ET
    $SABS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Tcg Crossover Gp Ii, Llc bought $444,844 worth of shares (18,856 units at $23.59) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/13/26 4:19:53 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Tcg Crossover Gp Ii, Llc bought $202,534 worth of shares (9,357 units at $21.65) (SEC Form 4)

    4 - Surrozen, Inc./DE (0001824893) (Issuer)

    2/3/26 8:03:54 PM ET
    $SRZN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: Large owner American Realty Investors Inc bought $3,886,276 worth of shares (70,023 units at $55.50), increasing direct ownership by 1% to 5,458,515 units (SEC Form 4)

    4/A - AMERICAN REALTY INVESTORS INC (0001102238) (Reporting)

    1/21/26 2:30:56 PM ET
    $ARL
    Other Consumer Services
    Real Estate

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Maris-Tech Ltd.

    SC 13G/A - Maris Tech Ltd. (0001872964) (Subject)

    12/13/24 11:34:57 AM ET
    $MTEK
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by Benitec Biopharma Inc.

    SC 13G/A - Benitec Biopharma Inc. (0001808898) (Subject)

    12/6/24 1:47:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Accelerate Diagnostics Inc.

    SC 13D/A - Accelerate Diagnostics, Inc (0000727207) (Subject)

    12/5/24 5:13:13 PM ET
    $AXDX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Leadership Updates

    Live Leadership Updates

    View All

    Royal Caribbean Group Appoints Christopher J. Wiernicki to Board of Directors

    MIAMI, Feb. 17, 2026 /PRNewswire/ -- Royal Caribbean Group (NYSE:RCL) today announced the appointment of Christopher J. Wiernicki, former Chairman & CEO, American Bureau of Shipping (ABS), to its Board of Directors, effective immediately. Wiernicki brings more than four decades of commercial, government and international experience in marine and offshore design, along with operations, infrastructure and safety management, ports and bunkering, digitalization, cyber security, and clean energy transition expertise.During his fourteen-year tenure at the helm of ABS, a global leader

    2/17/26 8:27:00 AM ET
    $RCL
    Marine Transportation
    Consumer Discretionary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    WISeKey and Partners Present the Human-AI-T Manifesto to at Davos 2026 during the WISeKey Event

    WISeKey and Partners Present the Human-AI-T Manifesto at Davos 2026 during the WISeKey Event Ensuring Human Control, Trust, and Values in the Age of AGI and Quantum Computing For more information visit: https://www.wisekey.com/embedding-human-values-into-ai/ Davos, Switzerland, January 19, 2026 – WISeKey International Holding Ltd ("WISeKey") ((SIX: WIHN, NASDAQ:WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces that in collaborations with its partners, gathered at the WISeKey Davos Event, will formally present the Human-AI-T (Human – Artificial Intelligence – Trust) Manifesto, a global framework designed to safeguard human sovereignty, trust, and ethical g

    1/19/26 1:00:00 AM ET
    $LAES
    $WKEY
    Semiconductors
    Technology
    EDP Services

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Financials

    Live finance-specific insights

    View All

    Wave Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and with higher doses of WVE-007 (INHBE GalNAc-siRNA), while preserving muscle mass Planning underway to initiate Phase 2a multidose portion of WVE-007 INLIGHT clinical trial for obesity in individuals with higher BMI and comorbidities in 1H 2026, as well as additional trials of WVE-007 as an incretin add-on and as post-incretin maintenance in 2026 Advancing regulatory engagement on potential accelerated approval pathway for WVE-006 (GalNAc-RNA editing) for AATD with feedback anticipated mid-2026; RestorAATion-2 clinical trial fully enrolled through 60

    2/26/26 7:30:00 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    CPI Card Group Inc. to Release Fourth Quarter and Full Year 2025 Results on March 5, 2026

    CPI Card Group Inc. (NASDAQ:PMTS) ("CPI Card Group"), a payments technology company providing a comprehensive range of physical and digital payment solutions, today announced it will host a webcast and conference call on Thursday, March 5, 2026 at 9:00 a.m. Eastern Time (ET) to discuss its fourth quarter and full year 2025 financial results. CPI Card Group's financial results for the fourth quarter will be released before the market opens on March 5, 2026. The press release and a slide presentation to accompany the earnings conference call will be available on the CPI Card Group investor website: CPI Card Group - Investor Relations (https://investor.cpicardgroup.com). The conference cal

    2/19/26 7:07:00 PM ET
    $PMTS
    Publishing
    Consumer Discretionary

    $AGTC
    $ANEB
    $ARL
    $AVTE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Led to the Purchase at Aerovate Therapeutics Inc. on Jun 20?

    Recently, on June 20, 2024, a notable insider purchase was made at Aerovate Therapeutics Inc. Director Ra Capital Management, L.P. bought $1,549,944 worth of shares, acquiring 928,110 units at $1.67 per share as reported in the SEC Form 4. Insider transactions like these are closely watched by investors as they can provide valuable insights into the company's prospects. When analyzing insider transactions, it is essential to look for patterns and trends among multiple transactions to gauge the overall sentiment within the company. Several other SEC Form 4 filings were made around the same time, on June 7, 2024, by various insiders at Aerovate Therapeutics Inc. These included transactions by

    6/21/24 3:23:59 PM ET
    $AVTE
    Biotechnology: Pharmaceutical Preparations
    Health Care